Allarity Therapeutics, Inc.
ALLR
$1.61
-$0.15-8.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -106.98% | -88.86% | -105.99% | -44.30% | 14.45% |
| Total Depreciation and Amortization | 38.10% | -37.93% | -75.68% | -43.33% | -34.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 297.74% | 282.06% | 267.85% | 348.92% | -131.98% |
| Change in Net Operating Assets | -393.34% | -152.70% | -98.54% | -147.08% | -70.15% |
| Cash from Operations | -6.76% | -70.33% | -36.15% | -17.01% | -25.50% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | -100.00% | 27.62% | -34.63% | -34.63% |
| Total Debt Repaid | 100.00% | 63.77% | 63.77% | 63.74% | 49.49% |
| Issuance of Common Stock | -48.00% | 152.67% | 95.18% | 80.73% | 487.12% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 153.28% | 153.28% | -100.00% |
| Repurchase of Preferred Stock | 30.00% | 47.38% | 47.40% | 47.40% | -202.30% |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -48.99% | 315.04% | 234.62% | 188.32% | 590.05% |
| Foreign Exchange rate Adjustments | -1,960.82% | 12.06% | 299.12% | 59.21% | -133.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -107.61% | 161,029.41% | 1,139.56% | 769.96% | 359.24% |